%0 Journal Article
%T Recent Advances in the Tracer Technology Used for Sentinel Lymph Node Biopsy in Breast Cancer
%A Jiali Li
%A Hongxu Zhang
%A Dawei Hu
%J Advances in Breast Cancer Research
%P 109-119
%@ 2168-1597
%D 2022
%I Scientific Research Publishing
%R 10.4236/abcr.2022.112009
%X The high
incidence of breast cancer poses one of the greatest risks to female health
worldwide. Sentinel lymph node biopsy (SLNB) is the standard of treatment for
patients with axillary lymph node-negative early-stage breast cancer. Herein,
the precise use of tracers is the key to ensuring the success of SLNB. However,
owing to select-few limitations of traditional tracers, their <span style=\"font-family:Verdana;\">clinical application is limited. New tracer
techniques, such as the near-infrared</span><span style=\"font-family:Verdana;\"> fluorescent dye method (using
indocyanine green), contrast-enhanced ultrasound, and superparamagnetic iron
oxide nanoparticles are being applied in clinical practice. In this paper, we
review the recent progress in SLNB tracer technology.</span>
%K Breast Cancer
%K Sentinel Lymph Node Biopsy
%K Tracer
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=116227